缺血性事件 (缺血性脑卒中、心肌梗死、血管性死亡 )是临床上动脉血栓形成性疾病患者的主要死亡原因 ,要改善这类患者的预后 ,减少死亡率 ,防治血栓形成就显得极为重要。而血小板活化在血栓形成中具有重要作用 ,故临床上常用包括抗血小板药在内的综合措施预防缺血性事件的发生 Ischemic (ischemic stroke, myocardial infarction, vascular death) is the main cause of death in patients with clinical arterial thrombotic disease, to improve the prognosis of such patients, reduce mortality, prevention and treatment of thrombosis is extremely important. Platelet activation in thrombosis has an important role, it is commonly used in clinical practice, including anti-platelet drugs, including comprehensive measures to prevent the occurrence of ischemic events